Topic: Cancer
WASHINGTON (Reuters) - An experimental approach that looks for the DNA leaking out from dead and dying cells may provide a route to a blood test for breast cancer, U.S. researchers reported on Tuesday. An initial study showed the test detected 70 percent of breast cancer cases, and correctly cleared 100 percent of women who did not have breast cancer ...
ImmunoGen Inc. said Monday the Food and Drug Administration and European regulators gave the company's potential cancer drug IMGN901 "orphan drug" status. Orphan drug status is given to drugs aimed at rare conditions or conditions that have a lack of treatments on the market. Incentives in the U ...
Medical lab operator Quest Diagnostics Inc. said Monday it is selling the OVA1 blood test, which aims to better assess a woman's likelihood for ovarian cancer. The OVA1 test, which was approved by the Food and Drug Administration in September, will be sold through Quest, based in Madison ...
